"[C7786FDCFFC0]" . "Odli\u0161n\u00FD efekt atorvastatinu na endoteli\u00E1ln\u00ED markery u r\u016Fzn\u00FDch my\u0161\u00EDch model\u016F ateroskler\u00F3zy"@cs . "RIV/00216208:11150/06:00004085" . "Journal of Pharmaceutical Sciences" . "9" . . . . . "9"^^ . . . "Odli\u0161n\u00FD efekt atorvastatinu na endoteli\u00E1ln\u00ED markery u r\u016Fzn\u00FDch my\u0161\u00EDch model\u016F ateroskler\u00F3zy"@cs . "\u017D\u010F\u00E1nsk\u00FD, Petr" . . . "Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis" . "atherosclerosis; VCAM-1; ICAM-1"@en . "Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis" . "2"^^ . . "11150" . . . "Atherosclerosis is progressive process that initially involves endothelial dysfunction: The effexcts of atorvastatin on both lipid parameters, and VCAM-1 and ICAM-1 expression in apoE-deficient or wild type C57BL/6J mice."@en . "Atherosclerosis is progressive process that initially involves endothelial dysfunction: The effexcts of atorvastatin on both lipid parameters, and VCAM-1 and ICAM-1 expression in apoE-deficient or wild type C57BL/6J mice." . . "Ateroskler\u00F3za je progresivn\u00ED proces, kter\u00FD ovliv\u0148uje endoteli\u00E1ln\u00ED dysfunkci. V pr\u00E1ci byl sledov\u00E1n efekt atorvastatinu na lipidov\u00E9 parametry a VCAM-1 a ICAM-1 expresi u apoE-deficientn\u00ED a C57BL/6J typu my\u0161i."@cs . . . "7"^^ . "2" . "Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis"@en . . . "RIV/00216208:11150/06:00004085!RIV07-MSM-11150___" . "Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis"@en . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "Solichov\u00E1, Dagmar" . "222;230" . "466289" . "P(GP304/03/P049), S" . . "0022-3549" .